[HTML][HTML] IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study

F Heinen, P Kanovský, AS Schroeder… - Journal of pediatric …, 2021 - content.iospress.com
PURPOSE: Investigate the efficacy and safety of multipattern incobotulinumtoxinA injections
in children/adolescents with lower-limb cerebral palsy (CP)-related spasticity. METHODS …

[HTML][HTML] IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study

F Heinen, P Kanovský, AS Schroeder… - Journal of Pediatric …, 2021 - ncbi.nlm.nih.gov
PURPOSE: Investigate the efficacy and safety of multipattern incobotulinumtoxinA injections
in children/adolescents with lower-limb cerebral palsy (CP)-related spasticity. METHODS …

IncobotulinumtoxinA For the Treatment of Lower-Limb Spasticity in Children and Adolescents With Cerebral Palsy: A Phase 3 Study.

F Heinen, P Kanovský… - Journal of …, 2021 - scholarlyworks.beaumont.org
PURPOSE: Investigate the efficacy and safety of multipattern incobotulinumtoxinA injections
in children/adolescents with lower-limb cerebral palsy (CP)-related spasticity. METHODS …

[引用][C] IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study

F Heinen, P Kanovský… - Journal of …, 2021 - scholars.northwestern.edu
IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with
cerebral palsy: A phase 3 study — Northwestern Scholars Skip to main navigation Skip to search …

IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study.

F Heinen, P Kanovský, AS Schroeder… - Journal of Pediatric …, 2021 - europepmc.org
Purpose Investigate the efficacy and safety of multipattern incobotulinumtoxinA injections in
children/adolescents with lower-limb cerebral palsy (CP)-related spasticity. Methods Phase …

IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study

F Heinen, P Kanovský… - Journal of pediatric …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose Investigate the efficacy and safety of multipattern incobotulinumtoxinA injections in
children/adolescents with lower-limb cerebral palsy (CP)-related spasticity. Methods Phase …

[引用][C] IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study

F Heinen, P Kanovsky, AS Schroeder… - Journal of Pediatric …, 2021 - ruj.uj.edu.pl
IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with
cerebral palsy : A phase 3 study W dniach od 2 kwietnia do 5 kwietnia 2024 r. prowadzone będą …

IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study

F Heinena, P Kanovskýb, AS Schroedera… - content.iospress.com
PURPOSE: Investigate the efficacy and safety of multipattern incobotulinumtoxinA injections
in children/adolescents with lower-limb cerebral palsy (CP)-related spasticity. METHODS …

IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study

F Heinen, P Kanovsky… - Journal of …, 2021 - epub.ub.uni-muenchen.de
PURPOSE: Investigate the efficacy and safety of multipattern incobotulinumtoxinA injections
in children/adolescents with lower-limb cerebral palsy (CP)-related spasticity. METHODS …

Erratum to: IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study

F Heinen, P Kanovský, AS Schroeder… - Journal of Pediatric …, 2021 - ncbi.nlm.nih.gov
“Patients in all three incobotulinumtoxinA dose groups (total body doses of 4, 8, and 16 U/kg
[maximum 100, 300, and 400 U]) experienced improvements in AS-PF scores on the primary …